Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

ClinicalTrials.gov ID: NCT00723190

Public ClinicalTrials.gov record NCT00723190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 11:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Chronic Exposure Evaluation of the Safety of CLONICEL (Clonidine HCl Sustained Release) in the Treatment of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this 12-month, multi-center, open-label study is to evaluate the safety of CLONICEL (clonidine HCl sustained release) when administered chronically under regular clinical conditions either as monotherapy or in combination with stimulant therapy to children and adolescents with attention deficit hyperactivity disorder (ADHD).

Study identification

NCT ID
NCT00723190
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shionogi
Industry
Enrollment
303 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2007
Primary completion
Feb 28, 2010
Completion
May 31, 2010
Last update posted
Apr 17, 2018

2008 – 2010

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
26
Facility City State ZIP Site status
Not listed Little Rock Arkansas 72205
Not listed El Centro California 92243
Not listed Irvine California 92612
Not listed San Diego California 92103
Not listed Bradenton Florida 34208
Not listed Gainesville Florida 32607
Not listed Jacksonville Florida 32216
Not listed Lauderhill Florida 33319
Not listed Miami Florida 33161
Not listed Orlando Florida 32806
Not listed Bardstown Kentucky 40004
Not listed Baltimore Maryland 21208
Not listed Rochester Hills Michigan 48307
Not listed St Louis Missouri 63005
Not listed Voorhees Township New Jersey 08043
Not listed Willingboro New Jersey 08046
Not listed Chapel Hill North Carolina 27514
Not listed Charlotte North Carolina 28209
Not listed Durham North Carolina 27705
Not listed Cleveland Ohio 44106
Not listed Oklahoma City Oklahoma 73103
Not listed Oklahoma City Oklahoma 73116
Not listed Houston Texas 77007
Not listed Lake Jackson Texas 77566
Not listed Wharton Texas 77488
Not listed Clinton Utah 84015
Not listed Kirkland Washington 98033

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00723190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2018 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00723190 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →